Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Breast Neoplasms and HGF[original query] |
---|
HGF and MET mutations in primary and secondary lymphedema. Lymphatic research and biology 2008 6 (2): 65-8. Finegold David N, Schacht Vivien, Kimak Mark A, Lawrence Elizabeth C, Foeldi Etelka, Karlsson Jenny M, Baty Catherine J, Ferrell Robert |
Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer. The Journal of clinical investigation 2009 Mar 119 (3): 478-91. Ma Jihong, DeFrances Marie C, Zou Chunbin, Johnson Carla, Ferrell Robert, Zarnegar Re |
Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Apr 18 (8): 2382-90. Finegold David N, Baty Catherine J, Knickelbein Kelly Z, Perschke Shelley, Noon Sarah E, Campbell Diana, Karlsson Jenny M, Huang Diana, Kimak Mark A, Lawrence Elizabeth C, Feingold Eleanor, Meriney Stephen D, Brufsky Adam M, Ferrell Robert |
The associations between immunity-related genes and breast cancer prognosis in Korean women. PloS one 2014 9 (7): e103593. Choi Jaesung, Song Nan, Han Sohee, Chung Seokang, Sung Hyuna, Lee Ji-young, Jung Sunjae, Park Sue K, Yoo Keun-Young, Han Wonshik, Lee Jong Won, Noh Dong-Young, Kang Daehee, Choi Ji-Ye |
Type II transmembrane serine protease gene variants associate with breast cancer. PloS one 2014 9 (7): e102519. Luostari Kaisa, Hartikainen Jaana M, Tengström Maria, Palvimo Jorma J, Kataja Vesa, Mannermaa Arto, Kosma Veli-Mat |
Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. European journal of cancer (Oxford, England : 1990) 2014 Aug 50 (12): 2134-41. Muendlein Axel, Hubalek Michael, Geller-Rhomberg Simone, Gasser Klaus, Winder Thomas, Drexel Heinz, Decker Thomas, Mueller-Holzner Elisabeth, Chamson Martina, Marth Christian, Lang Alois |
Functional consequence of the MET-T1010I polymorphism in breast cancer. Oncotarget 2015 1 6 (5): 2604-14. Liu Shuying, Meric-Bernstam Funda, Parinyanitikul Napa, Wang Bailiang, Eterovic Agda K, Zheng Xiaofeng, Gagea Mihai, Chavez-MacGregor Mariana, Ueno Naoto T, Lei Xiudong, Zhou Wanding, Nair Lakshmy, Tripathy Debu, Brown Powel H, Hortobagyi Gabriel N, Chen Ken, Mendelsohn John, Mills Gordon B, Gonzalez-Angulo Ana |
Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses. American journal of translational research 2018 10 (6): 1677-1689. Jin Zining, Xu Lu, Zhang Lei, Zhao Min, Li Dongbao, Ye Lijun, Ma Ying, Ren Siyu, Yu Hailan, Wang Danyu, Liang Chunyan, Chen |
Mendelian randomisation analysis of circulating adipokines and C-reactive protein on breast cancer risk. International journal of cancer 2020 Mar . Robinson Timothy, Martin Richard M, Yarmolinsky Jam |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: